Abstract
We have not added the abstract for this paper yet. The publisher's page has the full record.
The CDR-SB and other clinical trial mistakes made due to regulatory momentum
Alzheimer's & Dementia · Vol. 18 Published January 1, 2022
More on these topics
Browse all publications →-
2026 · The Journal of Prevention of Alzheimer's Disease
Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer’s disease
-
2025 · Alzheimer's & Dementia
Leveraging recent advances in plasma biomarkers to optimize early proof of concept trials in Alzheimer’s disease
-
2024 · J Prev Alzheimers Dis
Evaluation of Clinical Meaningfulness of Fortasyn Connect in Terms of "Time Saved"
-
2024 · Front Neurol
Safety, tolerability, and efficacy estimate of evoked gamma oscillation in mild to moderate Alzheimer's disease